SansRosa Pharmaceutical Development Inc.
This article was originally published in Start Up
Executive Summary
SansRosa, a Philadelphia-area start-up focused on dermatological conditions, is reprofiling a group of alpha agonists for use as treatments for rosacea and other disorders. The firm was founded in late 2002 and has so far raised $500,000 from Bioadvance to support its efforts.